Other content in this Stream
Rare Disease Case Study: Pediatric Sickle Cell Anemia
Our client, a Top 10 pharmaceutical company, needed to boost enrollment for their phase ll pediatric sickle cell anemia study.
Rare Disease Case Study: Familial Amyloidosis
Our client, a top-tier CRO, was faced with the challenge of enrolling for a non-interventional screening study in the familial amyloidotic cardiomyopathy (FAC) patient population.
Rare & Orphan Disease Endpoints: Challenges & Examples from Neurodevelopment
Recruiting Patients & Time Management: Top Tips for Dealing with the Most Critical Resource in Research
Personalized Medicine Requires Personalized Measurement
Patient Recruitment for Ophthalmology Study (Glaucoma and Retinal Disease)
A leading pharma company needed assistance to rescue their enrolling ophthalmology study. The sponsor was attempting to complete enrollment for a normative, glaucoma and retinal disease study.
Patient Recruitment for Multi-Protocol Global Program (Phase III Cardiovascular Disease)
Our customer needed support for a global, multi-protocol program which was behind with enrollment.
Looking Ahead to 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Six Practices of High Performing Clinical Research Sites
Learn what high-performing research sites have in common, and what makes sponsors return to them again and again.
Subject Recruitment Materials: Understanding the Requirements for IRB Review
Placebo Response in Clinical Trials: Approaches to Mitigation
Clinical Trial Recruitment Practices: The Evolution of Ethical Considerations
Clinical Trials and Social Media - Friends or Foes
Case Study: Engaging Research Naive Sites
Case Study: Customized Scale Development
Case Study: In-Study Quality Control
Case Study: Addressing Placebo Response
Case Study: Suicidality Assessment in China
Case Study: Training Program for Japan